811 related articles for article (PubMed ID: 18289643)
1. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand influences platelet release of reactive oxygen intermediates.
Chakrabarti S; Varghese S; Vitseva O; Tanriverdi K; Freedman JE
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2428-34. PubMed ID: 16141403
[TBL] [Abstract][Full Text] [Related]
3. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.
Inwald DP; McDowall A; Peters MJ; Callard RE; Klein NJ
Circ Res; 2003 May; 92(9):1041-8. PubMed ID: 12676820
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
[TBL] [Abstract][Full Text] [Related]
6. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
7. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
[TBL] [Abstract][Full Text] [Related]
8. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst.
Jin R; Yu S; Song Z; Zhu X; Wang C; Yan J; Wu F; Nanda A; Granger DN; Li G
PLoS One; 2013; 8(6):e64631. PubMed ID: 23785403
[TBL] [Abstract][Full Text] [Related]
11. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
13. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
14. The effect of dipyridamole on vascular cell-derived reactive oxygen species.
Chakrabarti S; Vitseva O; Iyu D; Varghese S; Freedman JE
J Pharmacol Exp Ther; 2005 Nov; 315(2):494-500. PubMed ID: 16046616
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury.
Rahman M; Zhang S; Chew M; Ersson A; Jeppsson B; Thorlacius H
Ann Surg; 2009 Nov; 250(5):783-90. PubMed ID: 19806052
[TBL] [Abstract][Full Text] [Related]
16. The CD40-CD40L system in cardiovascular disease.
Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
[TBL] [Abstract][Full Text] [Related]
17. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of CD40-CD40 ligand system in patients with essential hypertension.
Yan JC; Ma GS; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2005 May; 355(1-2):191-6. PubMed ID: 15820495
[TBL] [Abstract][Full Text] [Related]
20. The role of CD40L and VEGF in the modulation of angiogenesis and inflammation.
Chakrabarti S; Rizvi M; Morin K; Garg R; Freedman JE
Vascul Pharmacol; 2010; 53(3-4):130-7. PubMed ID: 20546942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
